“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Sunday, August 31, 2025

Biofrontera AG


Biofrontera AG products


  • Ameluz®

    • Generic: aminolevulinic acid hydrochloride topical gel, 10%

    • Indication: photodynamic therapy (PDT) for actinic keratoses of the face and scalp

    • Dose / Usage: apply ~1 mm layer (max 6 g per session, 60 cm² area), occlude 3 hours, then illuminate with red light (~37 J/cm²); retreat after 3 months if needed

  • Belixos® (Dermocosmetic line)

    • Generic: medical-grade skincare formulations

    • Indication: soothing, regenerating, and protecting inflamed, itchy, or photodamaged skin

    • Dose / Usage: apply topically as directed; varies by product (cosmetic use, not prescription drug)

  • BF-RhodoLED® / RhodoLED XL

    • Generic: red-light medical device (PDT lamp)

    • Indication: illumination device used in conjunction with Ameluz® for actinic keratosis treatment

    • Usage: delivers ~37 J/cm² red light over ~10 minutes; proper positioning and eye protection required

  • Xepi®

    • Generic: ozenoxacin cream, 1%

    • Indication: topical treatment of impetigo in adults and children ≥ 2 months

    • Dose / Usage: thin layer to affected area twice daily for 5 days; maximum area 100 cm² (≤ 2% body surface in children < 12 years)



No comments:

Post a Comment